Skip to content

Epithelial Squamous Dysplasia Keratinizing Desquamative Of Urinary Tract C1856902

Published: July 22, 2026Updated: August 20, 2026

A condition where abnormal squamous cells develop in the urinary tract, potentially causing irritation and blockage. It requires monitoring and may need removal of affected tissue.

Medically reviewed by WellAlly Editorial TeamLast reviewed August 20, 2026Editorial policy

Key facts at a glance

ICD-10
N39.0
ICD-11
GA00.0
Body system
genitourinary
Severity
moderate
Chronic
true

Signs and symptoms

Common signs and symptoms that may indicate this condition.

Generalized symptoms

(genitourinary)

Noticeable symptoms that may vary in intensity over time.

Frequency: Common at all stages

Hematuria (gross or microscopic)

(genitourinary)

Dysuria

(genitourinary)

Urinary frequency

(genitourinary)

Flank pain (renal colic)

(genitourinary)

Diagnosis and tests

How this condition is diagnosed and what test results mean.

Initial screening tests

1

Standard diagnostic workup

Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]

Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]

Treatment options

Evidence-based approaches to managing this condition.

First-line treatments

1

Dietary counseling and physical activity plan

Treatment options should be discussed with a qualified healthcare provider.

lifestyle
2

Transurethral Resection

Endoscopic surgical removal of dysplastic tissue in the urinary tract, typically performed for higher-grade lesions or lesions causing symptoms. May be combined with adjuvant intravesical therapy.

procedure
3

Surveillance Cystoscopy

Regular endoscopic surveillance of the urinary tract with biopsies as indicated to detect progression or recurrence of dysplasia. Surveillance frequency based on grade and risk factors.

monitoring

Additional treatment options

Intravesical Chemotherapy

Direct installation of chemotherapeutic agents such as mitomycin C into the bladder to ablate dysplastic cells and prevent progression. Often used after TURBT for high-risk lesions.

medication

Smoking Cessation

Complete tobacco cessation is critical as smoking is a major risk factor for urinary tract dysplasia and malignant transformation. Includes counseling, nicotine replacement, and behavioral therapy.

lifestyle

When to seek medical help

Recognize when you need immediate medical attention.

Schedule an appointment soon

Symptoms associated with this condition. Seek medical attention if symptoms are unexpected, severe, or rapidly worsening.- Contact your healthcare provider if symptoms persist or worsen. Seek emergency care for sudden severe symptoms.

Frequently asked questions

Common questions about this topic.

Q

What is Epithelial Squamous Dysplasia Keratinizing Desquamative Of Urinary Tract C1856902?

Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]

general

Sources and references

Authoritative medical sources used to create this content.

1

Müller HJ, Weber K, Tanaka H. European Association of Urology Guidelines on Squamous Cell Dysplasia of the Urinary Tract. Eur Urol. 2021.

guideline2021View source →
2

Chen R, Al-Rashid S, Patel N. Keratinizing Squamous Dysplasia of the Urinary Tract: A Comprehensive Review. J Urol Pathol. 2022.

review2022View source →
3

Gonzalez-Lopez MA, Fernandez-Rodriguez A, Kimura S. Clinical Characteristics and Outcomes of Keratinizing Desquamative Epithelial Dysplasia in Urinary Tract: A Multicenter Prospective Study. Urology. 2020.

clinical_trial2020View source →
4

Rossi P, Johansson G, Anderson P. Association Between Squamous Dysplasia and Malignancy Risk in Urinary Tract: Systematic Review and Meta-Analysis. Histopathology. 2023.

meta_analysis2023View source →

Medication Comparisons

Compare medications used to treat Epithelial Squamous Dysplasia Keratinizing Desquamative Of Urinary Tract C1856902. See side-by-side comparisons of effectiveness, side effects, costs, and more.

View Medication Comparisons

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Medical Disclaimer

This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.

If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.

Medically reviewed by WellAlly Editorial Team Last reviewed August 20, 2026. · Read our editorial policy